Europe (WHO region) vs Oman: Diphtheria tetanus toxoid and pertussis third-dose (DTP3)
Europe (WHO region)
91.0%
in 2025
Oman
99.0%
in 2025
Europe (WHO region) rank
3rd
Oman rank
1st
Diphtheria tetanus toxoid and pertussis third-dose (DTP3) over time
- Europe (WHO region)
- Oman
How they compare
Oman currently reports 99.0% against 91.0% in Europe (WHO region), a difference of 8.0%.
That makes Oman's figure about 1.1 times Europe (WHO region)'s.
Across all 26 years both countries report, Oman has been ahead every year.
Europe (WHO region) ranks 3rd and Oman ranks 1st of 11 groups.
Oman has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Europe (WHO region) | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 94.3% | 98.8% | 4.5% | Oman |
| 2010s | 93.5% | 98.8% | 5.3% | Oman |
| 2020s | 91.7% | 99.0% | 7.3% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher diphtheria tetanus toxoid and pertussis third-dose (dtp3), Europe (WHO region) or Oman?
- Oman, at 99.0% against 91.0% in Europe (WHO region) as of 2025.
- What is the difference in diphtheria tetanus toxoid and pertussis third-dose (dtp3) between Europe (WHO region) and Oman?
- 8.0%, with Oman ahead.
- How many years of comparable data are there for Europe (WHO region) and Oman?
- 26 years are reported by both, from 2000 to 2025.
- How do Europe (WHO region) and Oman rank globally for diphtheria tetanus toxoid and pertussis third-dose (dtp3)?
- Europe (WHO region) ranks 3rd and Oman ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Diphtheria tetanus toxoid and pertussis third-dose (DTP3) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.